Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin Type 2 Transmission in Bangladesh
NCT02477046Phase 3Unknown
- Sponsor
- University of Virginia
- Start
- Apr 2015
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes, Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of bivalent oral poliovirus vaccine, trivalent inactivated polio vaccine in poliomyelitis, sponsored by University of Virginia. Status: unknown.
02
Drugs
bivalent oral poliovirus vaccinetrivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02477046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477046.